T1	Outcomes 703 762	Echocardiographic, hemodynamic, and biochemical assessments
T2	Outcomes 914 1033	End-systolic wall stress, the left ventricular ejection fraction, pulmonary capillary wedge pressure, and cardiac index
T3	Outcomes 1145 1253	Plasma N-terminal-pro-B-type natriuretic peptide, tumor necrosis factor-alpha, and soluble Fas ligand levels
T4	Outcomes 1466 1479	interleukin-6
T5	Outcomes 1521 1579	Levosimendan-induced reduction in end-systolic wall stress
T6	Outcomes 1638 1679	N-terminal-pro-B-type natriuretic peptide
T7	Outcomes 1702 1729	tumor necrosis factor-alpha
T8	Outcomes 1752 1763	soluble Fas
T9	Outcomes 1790 1808	soluble Fas ligand
T10	Outcomes 1831 1850	Event-free survival
T11	Outcomes 1989 2009	central hemodynamics
T12	Outcomes 2014 2042	left ventricular performance
